Valuation: Hofseth BioCare ASA

Market Cap 695M 73.86M 64.3M 60.64M 55.12M 103M 7.08B 104M 725M 280M 3.6B 277M 271M 11.56B P/E 2024
-5.58x
P/E 2025 -4x
Enterprise Value 987M 105M 91.42M 86.21M 78.36M 146M 10.07B 147M 1.03B 399M 5.12B 394M 386M 16.43B EV / Sales 2024
3.18x
EV / Sales 2025 3.26x
Free-Float
76.37%
Yield 2024 *
-
Yield 2025 -
1 week-1.12%
Current month-4.32%
1 month-0.37%
3 months+16.67%
6 months-1.48%
Current year+0.76%
1 week 1.28
Extreme 1.28
1.44
1 month 1.26
Extreme 1.265
1.53
Current year 1.1
Extreme 1.1
2.01
1 year 1.1
Extreme 1.1
2.1
3 years 1.1
Extreme 1.1
3.6
5 years 1.1
Extreme 1.1
7.7
10 years 1.1
Extreme 1.1
10.95
Manager TitleAgeSince
Chief Executive Officer 53 31/07/2022
Director of Finance/CFO - 31/08/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 55 30/04/2015
Director/Board Member - -
Director/Board Member - 02/12/2021
Date Insider Type Main position Quantity % Market Cap. Importance
14/07/23 Buy 74,000 0.0187%
28/02/23 Buy

Chief Technology Officer

200,000 0.0506%
17/02/23 Buy

Director

100,000 0.0253%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.12%-26.11%-55.81% 73.75M
-2.63%-1.89%+6.67%-27.65% 244B
-1.92%-2.59%-3.15%-15.42% 79.18B
-1.37%-1.98%-18.08%+12.55% 45.33B
-3.30%-1.99%+39.43%+7.35% 42.46B
+0.87%-2.61%-11.15%-20.05% 33.82B
-0.99%-2.60%+14.45%+61.96% 30.34B
-1.21%+0.16%-5.05%-26.97% 29.33B
-1.38%-3.07%+12.37%+19.67% 27.62B
-3.13%-7.23%+43.74%+2.82% 22.92B
Average -1.51%-1.00%+5.31%-4.16% 55.55B
Weighted average by Cap. -2.06%-0.20%+6.28%-10.95%

Financials

2024 2025
Net sales 266M 28.24M 24.58M 23.18M 21.07M 39.22M 2.71B 39.64M 277M 107M 1.38B 106M 104M 4.42B 256M 27.26M 23.73M 22.38M 20.34M 37.86M 2.61B 38.27M 267M 103M 1.33B 102M 100M 4.27B
Net income -125M -13.32M -11.6M -10.94M -9.94M -18.51M -1.28B -18.71M -131M -50.58M -650M -50.05M -48.94M -2.08B -135M -14.34M -12.49M -11.78M -10.7M -19.92M -1.37B -20.14M -141M -54.45M -699M -53.87M -52.68M -2.24B
Net Debt 145M 15.45M 13.45M 12.68M 11.53M 21.46M 1.48B 21.69M 152M 58.66M 753M 58.04M 56.75M 2.42B 293M 31.14M 27.11M 25.57M 23.24M 43.26M 2.99B 43.73M 306M 118M 1.52B 117M 114M 4.87B
Logo Hofseth BioCare ASA
Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
Employees
81
Date Price Change Volume
18/09/26 NOK 1.330 0.00% 471,253
17/09/26 NOK 1.330 +2.31% 5,349
16/09/26 NOK 1.300 -3.70% 55,470
15/09/26 NOK 1.350 +3.85% 11,954
14/09/26 NOK 1.300 -3.35% 53,460
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!